Product Information

CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0169 per EA under NDC 64980065710. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Sep 12, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOBENZAPRINE 10 MG TABLET

Cyclobenzaprine Hydrochloride
$0.0169per EA

Strength

10 mg/1

NDC

64980065710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA218936

FDA Approved

9/12/2024

TE Code

AB

On Market Since

2/19/2025

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0169 per EA
All-time high$0.0192 (Sep 10, 2025)
All-time low$0.0169 (Aug 19, 2026)
52-week high$0.0192
52-week low$0.0169
Median price$0.0178
Average price$0.0180
Largest weekly change-2.7% (Oct 22, 2025)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

-2.1%

1M

-2.1%

3M

-4.2%

6M

-4.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.5%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0169 per EA (NDC 64980065710), effective Aug 19, 2026.

How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 11.5%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?

Since Aug 27, 2025, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0169 (Aug 19, 2026) to a high of $0.0192 (Sep 10, 2025), with a median of $0.0178 per EA.

Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CYCLOBENZAPRINE 10 MG TABLET?

CYCLOBENZAPRINE 10 MG TABLET (NDC 64980065710) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.